{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:36:50Z","timestamp":1783409810565,"version":"3.54.6"},"reference-count":33,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/jogm1897","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:13:06Z","timestamp":1760429586000},"page":"4182-4194","source":"Crossref","is-referenced-by-count":3,"title":["A comparative genomic analysis of left- and right-sided colon cancer using real-world data from the AACR project GENIE BPC dataset"],"prefix":"10.62347","volume":"15","author":[{"given":"Younggwang","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"ref1","unstructured":"Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gallinger S, Buchbinder A, Gordon G, Hawk E and Kirsch IR. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12: 755-762."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.gastro.2011.06.029","article-title":"One colon lumen but two organs","volume":"141","author":"Carethers","year":"2011","unstructured":"Carethers JM. One colon lumen but two organs. Gastroenterology 2011; 141: 411-412.","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000443644","article-title":"Right sided colon cancer as a distinct histopathological subtype with reduced prognosis","volume":"33","author":"Nitsche","year":"2016","unstructured":"Nitsche U, Stögbauer F, Späth C, Haller B, Wilhelm D, Friess H and Bader FG. Right sided colon cancer as a distinct histopathological subtype with reduced prognosis. Dig Surg 2016; 33: 157-163.","journal-title":"Dig Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anndiagpath.2006.03.003","article-title":"Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities","volume":"10","author":"Gualco","year":"2006","unstructured":"Gualco G, Reissenweber N, Cliché I and Bacchi CE. Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities. Ann Diagn Pathol 2006; 10: 333-338.","journal-title":"Ann Diagn Pathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","unstructured":"Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I and Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010; 53: 57-64.","journal-title":"Dis Colon Rectum"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejso.2014.11.001","article-title":"Is right-sided colon cancer different to left-sided colorectal cancer? - A systematic review","volume":"41","author":"Lee","year":"2015","unstructured":"Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO and Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer? - A systematic review. Eur J Surg Oncol 2015; 41: 300-308.","journal-title":"Eur J Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM and Wallace MB. Colorectal cancer. Lancet 2019; 394: 1467-1480.","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/cam4.1401","article-title":"Comparison of survival between right-sided and left-sided colon cancer in different situations","volume":"7","author":"Qiu","year":"2018","unstructured":"Qiu MZ, Pan WT, Lin JZ, Wang ZX, Pan ZZ, Wang FH, Yang DJ and Xu RH. Comparison of survival between right-sided and left-sided colon cancer in different situations. Cancer Med 2018; 7: 1141-1150.","journal-title":"Cancer Med"},{"key":"ref9","unstructured":"Hanna DL and Lenz HJ. How we treat left-sided vs. right-sided colon cancer. Clin Adv Hematol Oncol 2020; 18: 253-257."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Project GENIE Consortium","year":"2017","unstructured":"AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov 2017; 7: 818-831.","journal-title":"Cancer Discov"},{"key":"ref11","unstructured":"Kehl KL, Riely GJ, Lepisto EM, Lavery JA, Warner JL, LeNoue-Newton ML, Sweeney SM, Rudolph JE, Brown S, Yu C, Bedard PL, Schrag D and Panageas KS. Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non-small cell lung or colorectal cancer. JAMA Netw Open 2021; 4: e2117547."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3393\/ac.2019.03.17.1","article-title":"Immunological differences between right-sided and left-sided colorectal cancers: a comparison of embryologic midgut and hindgut","volume":"35","author":"Kwak","year":"2019","unstructured":"Kwak HD and Ju JK. Immunological differences between right-sided and left-sided colorectal cancers: a comparison of embryologic midgut and hindgut. Ann Coloproctol 2019; 35: 342-346.","journal-title":"Ann Coloproctol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.3390\/ijms24043265","article-title":"Colon cancer microbiome landscaping: differences in right- and left-sided colon cancer and a tumor microbiome-ileal microbiome association","volume":"24","author":"Kneis","year":"2023","unstructured":"Kneis B, Wirtz S, Weber K, Denz A, Gittler M, Geppert C, Brunner M, Krautz C, Siebenhüner AR, Schierwagen R, Tyc O, Agaimy A, Grützmann R, Trebicka J, Kersting S and Langheinrich M. Colon cancer microbiome landscaping: differences in right- and left-sided colon cancer and a tumor microbiome-ileal microbiome association. Int J Mol Sci 2023; 24: 3265.","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737140.2018.1442217","article-title":"Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype","volume":"18","author":"Yang","year":"2018","unstructured":"Yang S, Cho M and Kim N. Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype. Expert Review of Anticancer Therapy 2018; 18: 1-8.","journal-title":"Expert Review of Anticancer Therapy"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Qi GX, Zhao RX, Gao C, Ma ZY, Wang S and Xu J. Recent advances and challenges in colorectal cancer: from molecular research to treatment. World J Gastroenterol 2025; 31: 106964.","DOI":"10.3748\/wjg.v31.i21.106964"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbcan.2019.05.009","article-title":"Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation","volume":"1872","author":"Li","year":"2019","unstructured":"Li S, Peppelenbosch MP and Smits R. Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation. Biochim Biophys Acta Rev Cancer 2019; 1872: 74-79.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1020583","DOI":"10.3389\/fcimb.2022.1020583","article-title":"Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism","volume":"12","author":"Ou","year":"2022","unstructured":"Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, Guan Z, Wang Y, Hu H and Huang R. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. Front Cell Infect Microbiol 2022; 12: 1020583.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ejso.2021.10.007","article-title":"Survival outcomes for right-versus left-sided colon cancer and rectal cancer in england: a propensity-score matched population-based cohort study","volume":"48","author":"Hodges","year":"2022","unstructured":"Hodges N, Mackenzie H, D’Souza N, Brown G and Miskovic D. Survival outcomes for right-versus left-sided colon cancer and rectal cancer in england: a propensity-score matched population-based cohort study. Eur J Surg Oncol 2022; 48: 841-849.","journal-title":"Eur J Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"12306","DOI":"10.1038\/s41598-024-63143-3","article-title":"Prognostic factors and survival disparities in right-sided versus left-sided colon cancer","volume":"14","author":"Asghari-Jafarabadi","year":"2024","unstructured":"Asghari-Jafarabadi M, Wilkins S, Plazzer JP, Yap R and McMurrick PJ. Prognostic factors and survival disparities in right-sided versus left-sided colon cancer. Sci Rep 2024; 14: 12306.","journal-title":"Sci Rep"},{"key":"ref20","unstructured":"Salih S, Abdelhag I, Abdalla W, Mosad S and Hassan M. Computational detection of deleterious single nucleotide polymorphisms in human adenomatous polyposis coli gene the gate-keeper of colorectal carcinoma. Int J Comput Bioinfo In Silico Model 2014; 3: 531-537."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1634\/theoncologist.2019-0552","article-title":"Molecular analyses of left- and right-sided tumors in adolescents and young adults with colorectal cancer","volume":"25","author":"Salem","year":"2020","unstructured":"Salem ME, Battaglin F, Goldberg RM, Puccini A, Shields AF, Arguello D, Korn WM, Marshall JL, Grothey A and Lenz HJ. Molecular analyses of left- and right-sided tumors in adolescents and young adults with colorectal cancer. Oncologist 2020; 25: 404-413.","journal-title":"Oncologist"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","unstructured":"Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"672677","DOI":"10.3389\/fonc.2021.672677","article-title":"Beyond tumor mutation burden: tumor neoantigen burden as a biomarker for immunotherapy and other types of therapy","volume":"11","author":"Wang","year":"2021","unstructured":"Wang P, Chen Y and Wang C. Beyond tumor mutation burden: tumor neoantigen burden as a biomarker for immunotherapy and other types of therapy. Front Oncol 2021; 11: 672677.","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejca.2021.06.037","article-title":"Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: next-generation sequencing results of TRIBE2 study","volume":"155","author":"Antoniotti","year":"2021","unstructured":"Antoniotti C, Korn WM, Marmorino F, Rossini D, Lonardi S, Masi G, Randon G, Conca V, Boccaccino A, Tomasello G, Passardi A, Swensen J, Ugolini C, Oberley M, Tamburini E, Casagrande M, Domenyuk V, Fontanini G, Giordano M, Abraham J, Spetzler D, Falcone A, Lenz HJ and Cremolini C. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: next-generation sequencing results of TRIBE2 study. Eur J Cancer 2021; 155: 73-84.","journal-title":"Eur J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/modpathol.2009.80","article-title":"Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations","volume":"22","author":"Tougeron","year":"2009","unstructured":"Tougeron D, Fauquembergue E, Rouquette A, Le Pessot F, Sesboüé R, Laurent M, Berthet P, Mauillon J, Di Fiore F, Sabourin JC, Michel P, Tosi M, Frébourg T and Latouche JB. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol 2009; 22: 1186-1195.","journal-title":"Mod Pathol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2014.08.010","article-title":"The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype","volume":"55","author":"Fang","year":"2014","unstructured":"Fang M, Ou J, Hutchinson L and Green MR. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype. Mol Cell 2014; 55: 904-915.","journal-title":"Mol Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3748\/wjg.v21.i4.1275","article-title":"Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer","volume":"21","author":"Kadowaki","year":"2015","unstructured":"Kadowaki S, Kakuta M, Takahashi S, Takahashi A, Arai Y, Nishimura Y, Yatsuoka T, Ooki A, Yamaguchi K, Matsuo K, Muro K and Akagi K. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer. World J Gastroenterol 2015; 21: 1275-1283.","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3748\/wjg.v13.i28.3792","article-title":"Serrated neoplasia of the colorectum","volume":"13","author":"Harvey","year":"2007","unstructured":"Harvey NT and Ruszkiewicz A. Serrated neoplasia of the colorectum. World J Gastroenterol 2007; 13: 3792-3798.","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccr.2013.05.014","article-title":"A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention","volume":"24","author":"Rad","year":"2013","unstructured":"Rad R, Cadiñanos J, Rad L, Varela I, Strong A, Kriegl L, Constantino-Casas F, Eser S, Hieber M, Seidler B, Price S, Fraga MF, Calvanese V, Hoffman G, Ponstingl H, Schneider G, Yusa K, Grove C, Schmid RM, Wang W, Vassiliou G, Kirchner T, McDermott U, Liu P, Saur D and Bradley A. A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. Cancer Cell 2013; 24: 15-29.","journal-title":"Cancer Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.surg.2021.10.043","article-title":"The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer","volume":"171","author":"Tran","year":"2022","unstructured":"Tran CG, Goffredo P, Mott SL, Hart A, You YN, Vauthey JN, Weigel RJ and Hassan I. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer. Surgery 2022; 171: 657-665.","journal-title":"Surgery"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.6004\/jnccn.2017.7011","article-title":"KRAS testing, tumor location, and survival in patients with stage IV colorectal cancer: SEER 2010-2013","volume":"15","author":"Charlton","year":"2017","unstructured":"Charlton ME, Kahl AR, Greenbaum AA, Karlitz JJ, Lin C, Lynch CF and Chen VW. KRAS testing, tumor location, and survival in patients with stage IV colorectal cancer: SEER 2010-2013. J Natl Compr Canc Netw 2017; 15: 1484-1493.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Lavery JA, Brown S, Curry MA, Martin A, Sjoberg DD and Whiting K. A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package. Bioinformatics 2022; 39: btac796.","DOI":"10.1093\/bioinformatics\/btac796"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/9\/ajcr0167147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:23:58Z","timestamp":1768893838000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/9\/ajcr0167147.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/jogm1897","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}